← Back to guidelines
Cardiology29 papers

Infantile epiglottis

Last edited: 4/14/2026

Overview

Infantile haemangiomas are common benign vascular tumors of infancy, often localized but with segmental types carrying higher complication rates and potential associations with PHACE syndrome 2.

Diagnosis

  • Clinical appearance as localized or segmental skin lesions 2.
  • Imaging (ultrasound, CT, MRI) may be necessary for deeper or internal lesions 3.
  • Complications such as ulceration, bleeding, or organ obstruction should prompt further evaluation 23.
  • Management

  • First-line treatments:
  • - Systemic corticosteroids for segmental haemangiomas to arrest growth and reduce complications 2.
  • Adjunctive treatments:
  • - Propranolol for proliferating haemangiomas, with specific dosing protocols outlined in consensus guidelines 1. - Close monitoring for adverse effects, particularly with corticosteroid use 2.

    Special Populations

  • Pediatrics: Early recognition and intervention are crucial for reducing morbidity in infants with segmental haemangiomas 2.
  • Comorbidities: Consider potential side effects like hypertension, cushingoid features, and growth suppression with corticosteroid therapy 2.
  • Key Recommendations

  • Initiate systemic corticosteroids for segmental haemangiomas to prevent growth and manage complications (Evidence: Moderate 2).
  • Use propranolol for proliferating infantile haemangiomas following established dosing and monitoring protocols outlined in consensus guidelines (Evidence: Expert opinion 1).
  • Early multidisciplinary team involvement is beneficial for managing complications and side effects in infants with segmental haemangiomas (Evidence: Expert opinion 2).
  • References

    1 Solman L, Glover M, Beattie PE, Buckley H, Clark S, Gach JE et al.. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. The British journal of dermatology 2018. link 2 Phan TA, Adams S, Wargon O. Segmental haemangiomas of infancy: A review of 14 cases. The Australasian journal of dermatology 2006. link 3 Tan TH, Ong KL. Multiple haemangioma/haemangioendothelioma. Singapore medical journal 2001. link 4 McFadden N, Falk ES. Infantile acropustulosis. Cutis 1985. link

    Original source

    1. [1]
      Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines.Solman L, Glover M, Beattie PE, Buckley H, Clark S, Gach JE et al. The British journal of dermatology (2018)
    2. [2]
      Segmental haemangiomas of infancy: A review of 14 cases.Phan TA, Adams S, Wargon O The Australasian journal of dermatology (2006)
    3. [3]
      Multiple haemangioma/haemangioendothelioma.Tan TH, Ong KL Singapore medical journal (2001)
    4. [4]
      Infantile acropustulosis.McFadden N, Falk ES Cutis (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG